AXA/2025/FY/Earnings presentation: Difference between revisions

Content deleted Content added
PlumBot: publish from draft
 
PlumBot: publish from draft
Line 19:
=== Full Year 2025 earnings presentation ===
 
* PresentationFull date:Year February2025 26,Earnings 2026Presentation <sup>p. 1</sup>
* February 26, 2026 <sup>p. 1</sup>
 
=== Important legal information and cautionary statements concerning forward-looking statements and the use of non-GAAP financial measures ===
 
* Certain statements are forward-looking, including predictions of future events, trends, plans, expectations, or objectives, and are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target' or conditional verbs such as 'would' and 'could' <sup>p. 2</sup>.
* Statements regarding expected '''underlying earnings per share''' ('UEPS') growth for 2026 are forward-looking statements providing one-off guidance for the last year of the Group's current strategic plan <sup>p. 2</sup>.
* Forward-looking statements are identified by words like 'expects', 'anticipates', 'may', 'plan,' 'target', 'would', and 'could' <sup>p. 2</sup>.
* Statements regarding expected '''underlying earnings per share (UEPS)''' growth for 2026 are forward-looking statements providing one-off guidance for the last year of the Group's current strategic plan <sup>p. 2</sup>.
* These statements are based on Management's current views and intentions and are subject to change <sup>p. 2</sup>.
* Undue reliance should not be placed on forward-looking statements due to known and unknown risks and uncertainties, many outside AXA's control, which could cause actual results to differ materially <sup>p. 2</sup>.
* Each forward-looking statement speaks only at the date of this presentation <sup>p. 2</sup>.
* Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for important factors, risks, and uncertainties <sup>p. 2</sup>.
* Refer to Part 5 'Risk Factors and Risk Management' of AXA's Universal Registration Document for the year ended December 31, 2024 (the '2024 Universal Registration Document') for a description of important factors, risks, and uncertainties <sup>p. 2</sup>.
* AXA disclaims any obligation to publicly update or revise forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>.
* AXA disclaims any obligation to publicly update or revise any forward-looking statements, except as required by applicable laws and regulations <sup>p. 2</sup>.
* This presentation refers to non-GAAP financial measures, or alternative performance measures ('APMs'), used by Management for analyzing operating trends, financial performance, and position <sup>p. 2</sup>.
* NonThis presentation refers to certain non-GAAP financial measures, generallyor havealternative noperformance standardizedmeasures meaning('APMs'), andused mayby notManagement befor comparableanalyzing tooperating similarlytrends, labeledfinancial measuresperformance, usedand by otherfinancial companiesposition <sup>p. 2</sup>.
* NonThese non-GAAP financial measures shouldgenerally nothave beno consideredstandardized inmeaning isolationand from,may ornot asbe acomparable substituteto for,similarly thelabeled Group's consolidated financial statements preparedmeasures inused accordanceby withother IFRScompanies <sup>p. 2</sup>.
* None of these non-GAAP financial measures should be considered in isolation from, or as a substitute for, the Group's consolidated financial statements and related notes prepared in accordance with IFRS <sup>p. 2</sup>.
* '''Underlying earnings''', '''UEPS''' ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and AMF's related position statement <sup>p. 2</sup>.
* '''Underlying earnings''', UEPS ('underlying earnings per share'), '''underlying return on equity''', '''combined ratio''', and '''debt gearing''' are APMs as defined in ESMA's guidelines and the AMF's related position statement issued in 2015 <sup>p. 2</sup>.
* AXA provides a reconciliation of APMs to financial statements in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>.
* AXA provides a reconciliation of such APMs to the most closely related line item, subtotal, or total in the financial statements of the corresponding period (and/or their calculation methodology) in its Activity Report as of December 31, 2025 ('AXA's 2025 Activity Report'), under the heading 'Use of non-GAAP and alternative performance measures' <sup>p. 2</sup>.
* AXA's 2025 Activity Report is available on the AXA Group website (www.axa.com) <sup>p. 2</sup>.
* For further information on non-GAAP financial measures, see the Glossary in AXA's 2025 Activity Report <sup>p. 2</sup>.
* AXA's consolidated financial statements for the year ended December 31, 2025, were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors <sup>p. 2</sup>.
* AXA's Activity Report as of December 31, 2025 is available on the AXA Group website (www.axa.com) <sup>p. 2</sup>.
* AXA's consolidated financial statements for the year ended December 31, 2025 were examined by the Board of Directors on February 25, 2026, and are subject to completion of an audit procedure by AXA's statutory auditors <sup>p. 2</sup>.
 
=== Table of contents ===
 
* '''1. FY25 Highlights''': presented by Thomas Buberl, Group CEO, starting on page 04 <sup>p. 3</sup>.
* '''2. FY25 Business Performance''': presented by Guillaume Borie, Global Head of Finance, Strategy, Underwriting, Risk, and Technology, starting on page 09 <sup>p. 3</sup>.
* '''3. FY25 Financial Performance''': presented by Alban de Mailly Nesle, Group CFO, starting on page 13 <sup>p. 3</sup>.
 
== FY25 Highlights ==
Line 48 ⟶ 50:
=== 1 FY25 Highlights ===
 
* PresentedFY25 by Thomas Buberl, Group CEOHighlights <sup>p. 4</sup>.
* Thomas Buberl, Group CEO <sup>p. 4</sup>
 
=== Full Year 2025 | Excellent performance ===
 
* '''Revenues''' +6% vs. FY24 <sup>p. 5</sup>.
* '''Underlying EPS''' +8% vs. FY24 <sup>p. 5</sup>.
* '''ROE''' (FY25): 16% <sup>p. 5</sup>.
* '''Solvency II ratio''' (FY25): 224% <sup>p. 5</sup>.
* Delivering value for shareholders with +8% '''DPS''' +8% growth and EUR 1.25bn annual share buybackbuy back <sup>p. 5</sup>.
** '''DPS''' growth is based on the dividend proposed by AXA's Board of Directors on February 25, 2026, and is subject to approval by the Shareholders' Annual General Meeting on April 30, 2026 <sup>p. 5</sup>.
** The annual share buybackbuy isback followingfollows AXA's Board of Directors' approval on February 25, 2026, and is expected to commence as soon as reasonably practicable, subject to market conditions <sup>p. 5</sup>.
* Confident to deliver '''underlying EPS growth''' at the upper end of 6%-8% target range for 2026 <sup>p. 5</sup>.
 
=== Executing the plan on growth, margin and efficiency ===
 
<div style="overflow-x:auto">
* '''High organic growth''': +6% top line growth, well balanced across lines (P&C: +5%, Life: +9%, Health: +5%) <sup>p. 6</sup>
{| class="wikitable"
* '''Record profitability''': Further margin expansion in P&C and L&H; improvement in efficiency <sup>p. 6</sup>
*|+ '''ScalingUnderlying theearnings business''':and Continued investments inorganic growth andby technologyline <sup>p. 6</sup>
! style="text-align:left" | Metric
* Consistent earnings growth while enhancing reserve prudence <sup>p. 6</sup>
! class="col-s" style="text-align:right" | FY24
* (bar) '''Underlying earnings''' (in Euro billion): FY24 EUR 8.1bn; FY25 EUR 8.4bn (+6% overall, +9% excluding AXA IM) <sup>p. 6</sup>
! class="col-s" style="text-align:right" | FY25
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 6</sup>
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | Underlying earnings
| class="col-s" style="text-align:right" | EUR 8.1bn
| class="col-s" style="text-align:right" | EUR 8.4bn
| class="col-s" style="text-align:right" | +6% overall, +9% excluding AXA IM
|-
| style="text-align:left" | Top line growth
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +6%
|-
| style="text-align:left" | P&C
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +5%
|-
| style="text-align:left" | Life
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +9%
|-
| style="text-align:left" | Health
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | —
| class="col-s" style="text-align:right" | +5%
|}
</div>
 
=== Diversified franchise, well positioned in an attractive industry ===
 
<div style="overflow-x:auto">
* '''Secular trends fueling demand across businesses''': <sup>p. 7</sup>
{| class="wikitable fintable"
** Protection gaps and emerging corporate risks <sup>p. 7</sup>
**|+ DemographicsFY25 drivinggross demandwritten forpremium private retirement and healthcaresplit <sup>p. 7</sup>
! style="text-align:left" | Segment
* (donut) '''FY25 gross written premium split''' (excluding AXA IM and holdings): <sup>p. 7</sup>
! class="col-s" style="text-align:right" | Share
** Life: 33% <sup>p. 7</sup>
|-
** Health: 17% <sup>p. 7</sup>
| style="text-align:left" | Life
** Large & Specialty: 17% <sup>p. 7</sup>
| style="text-align:right" | 33%
** SME & Mid-market: 16% <sup>p. 7</sup>
|-
** Retail: 17% <sup>p. 7</sup>
| style="text-align:left" | Health
* '''Our right to win''': <sup>p. 7</sup>
| style="text-align:right" | 17%
** Leading brand & high customer NPS <sup>p. 7</sup>
|-
** Strong and diversified distribution <sup>p. 7</sup>
| style="text-align:left" | Large & Specialty
** Technical expertise to price & underwrite risks <sup>p. 7</sup>
| style="text-align:right" | 17%
** Scale offering cost advantage <sup>p. 7</sup>
|-
| style="text-align:left" | SME & Mid-market
| style="text-align:right" | 16%
|-
| style="text-align:left" | Retail
| style="text-align:right" | 17%
|}
</div>
 
=== Laying the foundation for the next plan ===
 
* (diagramicon) '''Clear tech and AI roadmap''' <sup>p. 8</sup>
* (diagramicon) '''Driving efficiency''' <sup>p. 8</sup>
* (diagramicon) '''Enhancing capital allocation discipline''' <sup>p. 8</sup>
* (diagramicon) '''Building resilience''' <sup>p. 8</sup>
* Confidence in sustaining earnings growth <sup>p. 8</sup>
 
* 2 <sup>p. 9</sup>
* FY25 Business Performance <sup>p. 9</sup>
* Guillaume Borie <sup>p. 9</sup>
* Global Head of Finance, Strategy, Underwriting, Risk, and Technology <sup>p. 9</sup>
* FY25 Business Performance <sup>p. 9</sup>
 
== Strong delivery across our businesses ==
Line 104 ⟶ 142:
=== Strong delivery across our businesses ===
 
* '''France''' (27% of total GWP¹): <sup>p. 10</sup>
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 10</sup>
** FY25 gross'''Gross written premiums''' excluding AXA IM, Holdings, AXA Assistance, and+6% AXAto LiabilitiesEUR Managers31bn <sup>p. 10</sup>
** '''Underlying earnings''' +7% to EUR 2.2bn <sup>p. 10</sup>
 
* '''Europe''' (38% of total GWP¹): <sup>p. 10</sup>
<div style="overflow-x:auto">
** '''Gross written premiums''' +6% to EUR 43bn <sup>p. 10</sup>
{| class="wikitable"
** '''Underlying earnings''' +9% to EUR 3.5bn <sup>p. 10</sup>
! style="text-align:left" | —
* '''AXA XL''' (17% of total GWP¹): <sup>p. 10</sup>
! class="col-m" style="text-align:right" | Gross written premiums
** '''Gross written premiums''' +4% to EUR 19bn <sup>p. 10</sup>
! class="col-m" style="text-align:right" | Underlying earnings
** '''Underlying earnings''' +9% to EUR 1.9bn <sup>p. 10</sup>
|-
| style="text-align:left" |* '''FranceAsia, Africa & EME-LATAM''' (2718% of total GWP¹): <sup>p. 10</sup>
** '''Gross written premiums''' +13% to EUR 20bn <sup>p. 10</sup>
| class="col-m" style="text-align:right" | +6% to EUR 31bn
** '''Underlying earnings''' +6% to EUR 1.5bn <sup>p. 10</sup>
| class="col-m" style="text-align:right" | +7% to EUR 2.2bn
* Change for Gross written premiums at constant scope and FX and for underlying earnings at constant FX <sup>p. 10</sup>.
|-
* ¹ FY25 gross written premiums excluding AXA IM, Holdings, AXA Assistance, and AXA Liabilities Managers <sup>p. 10</sup>.
| style="text-align:left" | '''Europe''' (38% of total GWP¹)
| class="col-m" style="text-align:right" | +6% to EUR 43bn
| class="col-m" style="text-align:right" | +9% to EUR 3.5bn
|-
| style="text-align:left" | '''AXA XL''' (17% of total GWP¹)
| class="col-m" style="text-align:right" | +4% to EUR 19bn
| class="col-m" style="text-align:right" | +9% to EUR 1.9bn
|-
| style="text-align:left" | '''Asia, Africa & EME-LATAM''' (18% of total GWP¹)
| class="col-m" style="text-align:right" | +13% to EUR 20bn
| class="col-m" style="text-align:right" | +6% to EUR 1.5bn
|}
</div>
 
=== P&C | Strong margins, confidence in sustaining growth ===
Line 135 ⟶ 161:
* '''Underlying earnings''' +9% to EUR 5.9bn (change FY25 vs. FY24 at constant FX) <sup>p. 11</sup>
* (donut) '''GWP''' EUR 58bn <sup>p. 11</sup>
** '''Retail''': 34% <sup>p. 11</sup>
** '''SME & Mid-market''': 33% <sup>p. 11</sup>
** '''AXA XL''' (Large & Specialty): 33% (includes AXA XL Re premiums of EUR 2.6bn) <sup>p. 11</sup>
* (diagram) '''2025 Strategic initiativesFocus''' <sup>p. 11</sup>
** '''2025Retail and SME & Mid-market''': Growing volumes while expanding margins <sup>p. 11</sup>
*** Retail'''AXA andXL''' SME(Large & Mid-marketSpecialty): GrowingProfitable volumesgrowth whilewith expandingstable margins <sup>p. 11</sup>
*** AXA XL (Large & Specialtydiagram): Profitable growth'''Beyond with2025 stableStrategic marginsFocus''' <sup>p. 11</sup>
** '''BeyondRetail 2025and SME & Mid-market''': Investing to improve customer retention & expanding distribution footprint <sup>p. 11</sup>
*** Retail'''AXA andXL''' SME(Large & Mid-marketSpecialty): InvestingCapitalizing toon improveattractive customergrowth retentionopportunities &and expandingcontinued distributioncycle footprintmanagement <sup>p. 11</sup>
* (diagram) '''Additional Strategic Initiatives''' <sup>p. 11</sup>
*** AXA XL (Large & Specialty): Capitalizing on attractive growth opportunities and continued cycle management <sup>p. 11</sup>
** '''AdditionalContinued initiatives'''progress on efficiency <sup>p. 11</sup>
*** ContinuedHigher progressinvestment on efficiencyincome <sup>p. 11</sup>
*** HigherData investment& incomeAI to further enhance customer experience & technical excellence <sup>p. 11</sup>
*** Data & AI to further enhance customer experience & technical excellence <sup>p. 11</sup>
 
=== L&H | Good momentum, well positioned to capture growth opportunities ===
Line 154 ⟶ 179:
* '''Underlying earnings''' +7% to EUR 3.5bn (change FY25 vs. FY24 at constant FX) <sup>p. 12</sup>
* (donut) '''GWP''' EUR 57bn <sup>p. 12</sup>
** '''Short-term''': 28% <sup>p. 12</sup>
** '''Long-term''': 72% <sup>p. 12</sup>
* (diagram) '''2025 Strategic initiativesFocus''' <sup>p. 12</sup>
** '''2025Long-term business''': Accelerating net flows in Savings at attractive margins <sup>p. 12</sup>
*** Long'''Short-term business''': AcceleratingGrowing nettechnical flowsresults inwhile Savingsabsorbing atMexico attractiveVAT marginsimpact <sup>p. 12</sup>
*** Short-term(diagram) business:'''Beyond Growing2025 technicalStrategic results while absorbing Mexico VAT impactFocus''' <sup>p. 12</sup>
** '''Long-term business''': Capturing savings & retirement opportunity, sourcing best asset management products for our customers <sup>p. 12</sup>
** '''Beyond 2025''' <sup>p. 12</sup>
*** Long'''Short-term business''': CapturingCapitalizing savingson &demand retirementfor opportunity,health sourcing& bestprotection assetwhile managementfurther products forimproving our customersmargins <sup>p. 12</sup>
* (diagram) '''Additional Strategic Initiatives''' <sup>p. 12</sup>
*** Short-term business: Capitalizing on demand for health & protection while further improving our margins <sup>p. 12</sup>
** '''AdditionalFocus initiatives'''on cost reduction <sup>p. 12</sup>
*** FocusIncreasing onpenetration costof reductionProtection riders in Savings offerings <sup>p. 12</sup>
*** IncreasingLeveraging penetrationAI ofto Protectionreduce ridersclaims inleakage Savings& improve customer outcomes in offeringsHealth <sup>p. 12</sup>
*** Leveraging AI to reduce claims leakage & improve customer outcomes in Health <sup>p. 12</sup>
 
* '''FY25 Financial Performance''' <sup>p. 13</sup>
* Alban de Mailly Nesle, Group CFO <sup>p. 13</sup>
* Group CFO <sup>p. 13</sup>
 
=== P&C | Continued disciplined growth ===
 
* (stacked bar) '''GWP & Other Revenues''' <sup>p. 14</sup>
** '''FY24 Total''': EUR 56.5bn <sup>p. 14</sup>
*** Commercial lines: EUR 35.8bn <sup>p. 14</sup>
*** AXA XL Reinsurance: EUR 2.6bn <sup>p. 14</sup>
*** Retail lines: EUR 18.1bn <sup>p. 14</sup>
** '''FY25 Total''': EUR 58.0bn <sup>p. 14</sup>
*** Commercial lines: EUR 35.8bn <sup>p. 14</sup>
*** AXA XL Reinsurance: EUR 2.6bn <sup>p. 14</sup>
*** Retail lines: EUR 19.7bn <sup>p. 14</sup>
* (table) '''ChangeCommercial in GWP & Other Revenueslines''': +4% change (ato/w pricing constant+2%, scopeo/w andvolume FX+2%) <sup>p. 14</sup>
** Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>
* '''AXA XL Reinsurance''': +8% change (o/w pricing +0.3%, o/w volume +7%) <sup>p. 14</sup>
** Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>
** Growth supported by alternative capital <sup>p. 14</sup>
* '''Retail lines''': +7% change (o/w pricing +5%, o/w volume +2%) <sup>p. 14</sup>
** Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>
* Change at constant scope and FX <sup>p. 14</sup>
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Combined ratio breakdown <sup>p. 15</sup>
! style="text-align:left" | Line
! class="col-s" style="text-align:rightleft" | ChangeComponent
! class="col-s" style="text-align:right" | o/w pricingFY24
! class="col-s" style="text-align:right" | o/w volumeFY25
|-
| style="text-align:left" | CommercialUndiscounted linesCY loss ratio (ex Nat Cat)
| style="text-align:right" | +67.4%
| style="text-align:right" | +267.0%
| style="text-align:right" | +2%
|-
| style="text-align:left" | AXAExpense XL Reinsuranceratio
| style="text-align:right" | +825.0%
| style="text-align:right" | +024.38%
| style="text-align:right" | +7%
|-
| style="text-align:left" | RetailNat linesCat
| style="text-align:right" | +73.8%
| style="text-align:right" | +53.4%
|-
| style="text-align:right" | +2%
| style="text-align:left" | Prior year reserve development
| style="text-align:right" | -1.6%
| style="text-align:right" | -1.1%
|-
| style="text-align:left" | Discount
| style="text-align:right" | -3.6%
| style="text-align:right" | -3.5%
|-
| style="text-align:left" | '''Total Combined Ratio'''
| style="text-align:right" | '''91.0%'''
| style="text-align:right" | '''90.6%'''
|}
</div>
 
* Continued pricing momentum and volume growth in Mid-market and SME <sup>p. 14</sup>
* Growing in lines of business with attractive margins while remaining focused on retention at AXA XL Insurance <sup>p. 14</sup>
* Growth supported by alternative capital <sup>p. 14</sup>
* Favorable pricing trends and strong growth in net new contracts (+1.7m in FY25) <sup>p. 14</sup>
 
=== P&C | Delivering further margin expansion while enhancing reserve prudence ===
 
* (stacked bar) '''Combined ratio''' <sup>p. 15</sup>
** '''FY24 Total Combined Ratio''': 91.0% <sup>p. 15</sup>
*** Undiscounted CY loss ratio (ex Nat Cat): 67.4% <sup>p. 15</sup>
*** Expense ratio: 25.0% <sup>p. 15</sup>
*** Nat Cat: 3.8% <sup>p. 15</sup>
*** Prior year reserve development: -1.6% <sup>p. 15</sup>
*** Discount: -3.6% <sup>p. 15</sup>
** '''FY25 Total Combined Ratio''': 90.6% <sup>p. 15</sup>
*** Undiscounted CY loss ratio (ex Nat Cat): 67.0% <sup>p. 15</sup>
*** Expense ratio: 24.8% <sup>p. 15</sup>
*** Nat Cat: 3.4% <sup>p. 15</sup>
*** Prior year reserve development: -1.1% <sup>p. 15</sup>
*** Discount: -3.5% <sup>p. 15</sup>
* Better undiscounted current year loss ratio excluding Nat Cat from: <sup>p. 15</sup>
** Margin expansion in Commercial lines SME & mid-market business and Personal lines reflecting favorable pricing environment <sup>p. 15</sup>
** Stable AXA XL Insurance margins at attractive levels reflecting disciplined cycle management <sup>p. 15</sup>
* Improvement in expense ratio reflecting the impact of efficiency measures, while continuing to invest in growth initiatives and technology <sup>p. 15</sup>
* Nat Cat charges below normalized load <sup>p. 15</sup>
* Lower reliance on prior year reserve development <sup>p. 15</sup>
* Taking advantage of a good year to enhance reserve prudence <sup>p. 15</sup>
 
=== P&C | Earnings growth from higher underwriting and financial result ===
 
* (waterfall) '''Underlying Earnings''' +9% to EUR 5,872m (FY25)change fromat EURconstant 5,510m (FY24FX) <sup>p. 16</sup>
* (waterfall) '''Underlying Earnings''' FY24 to FY25:
** FY24: EUR 5,510m <sup>p. 16</sup>
** '''Volume growth''': +EUR 292m <sup>p. 16</sup>
** '''Margin improvement''': +EUR 189m <sup>p. 16</sup>
Line 245 ⟶ 262:
** '''Tax''': -EUR 169m <sup>p. 16</sup>
** '''Affiliates, FX & other''': -EUR 150m <sup>p. 16</sup>
** FY25: EUR 5,872m <sup>p. 16</sup>
* '''Better underwriting result''' from strong volume growth and improved all-year combined ratio while enhancing reserve prudence <sup>p. 16</sup>
* '''Increase in investment income''' reflecting higher volumes and better reinvestment yields on fixed income assets <sup>p. 16</sup>
Line 252 ⟶ 270:
=== Life & Health | Strong growth in premiums, positive net flows ===
 
* (stacked bar) '''Life GWP & Other Revenues''' +9% to(change EURat 37.5bnconstant (FY25)scope fromand EUR 34.5bn (FY24FX) <sup>p. 17</sup>
** '''Protection'''FY24 Total: EUR 1934.0bn (+11%) (FY25) vs. EUR 17.3bn (FY24)5bn <sup>p. 17</sup>
*** '''Unit-linkedProtection''': EUR 10.5bn (+13%) (FY25) vs. EUR 917.3bn (FY24) <sup>p. 17</sup>
*** '''Capital light G/AUnit-linked''': EUR 69.1bn (+7%) (FY25) vs. EUR 6.0bn (FY24)3bn <sup>p. 17</sup>
*** '''TraditionalCapital light G/A''': EUR 16.9bn (-7%) (FY25) vs. EUR 1.9bn (FY24)0bn <sup>p. 17</sup>
* (stacked bar)** '''HealthTraditional GWP & Other RevenuesG/A''' +5% to: EUR 191.0bn (FY25) from EUR 17.5bn (FY24)9bn <sup>p. 17</sup>
** '''Individual''': EUR 11.1bn (+6%) (FY25) vs.Total: EUR 1037.5bn (FY24) <sup>p. 17</sup>
*** '''GroupProtection''': EUR 719.9bn0bn (+411%) (FY25) vs. EUR 7.0bn (FY24) <sup>p. 17</sup>
* (bar)** '''Net flowsUnit-linked''': EUR +510.4bn5bn (FY25) vs. EUR +1.5bn (FY2413%) <sup>p. 17</sup>
*** '''Capital light G/A''': EUR 6.1bn (+7%) <sup>p. 17</sup>
*** '''Traditional G/A''': EUR 1.9bn (-7%) <sup>p. 17</sup>
* (bar) '''Health GWP & Other Revenues''' +5% (change at constant scope and FX) <sup>p. 17</sup>
** FY24 Total: EUR 17.5bn <sup>p. 17</sup>
*** '''Individual''': EUR 10.5bn <sup>p. 17</sup>
*** '''Group''': EUR 7.0bn <sup>p. 17</sup>
** FY25 Total: EUR 19.0bn <sup>p. 17</sup>
*** '''Individual''': EUR 11.1bn (+6%) <sup>p. 17</sup>
*** '''Group''': EUR 7.9bn (+4%) <sup>p. 17</sup>
* (bar) '''Net flows''': EUR +5.4bn vs. EUR +1.5bn in FY24 <sup>p. 17</sup>
** '''Protection''': +EUR 4.9bn <sup>p. 17</sup>
** '''Health''': +EUR 2.7bn <sup>p. 17</sup>
Line 266 ⟶ 294:
** '''Capital light G/A''': +EUR 1.2bn <sup>p. 17</sup>
** '''Traditional G/A''': -EUR 5.0bn <sup>p. 17</sup>
* '''Employee Benefits''' (o/wincluding FY25both short-term and long-term Employee Benefits GWP and other revenues) FY25: EUR 12.9bn (+4% vs. FY24) <sup>p. 17</sup>
 
=== Life & Health | Strong volume growth in Savings and Protection impacted by higher interest rates on discounting ===
 
<div style="overflow-x:auto">
* (stacked bar) '''PVEP''' -2% to EUR 49.4bn (FY25) from EUR 50.9bn (FY24) <sup>p. 18</sup>
{| class="wikitable"
** '''Protection & Health''': EUR 31.4bn (-4%) (FY25) vs. EUR 39.4bn (FY24) <sup>p. 18</sup>
**|+ '''Unit-Linked''':PVEP EURby 8.5bnsegment, (+18%) (FY25)FY24 vs. EUR 8.5bn (FY24)FY25 <sup>p. 18</sup>
! style="text-align:left" | Segment
** '''Capital-light G/A''': EUR 7.8bn (-10%) (FY25) vs. EUR 2.0bn (FY24) <sup>p. 18</sup>
! class="col-s" style="text-align:right" | FY24 Total
** '''Traditional G/A''': EUR 1.7bn (-10%) (FY25) vs. EUR 1.0bn (FY24) <sup>p. 18</sup>
! class="col-s" style="text-align:right" | FY25 Total
* '''PVEP''' was impacted by higher interest rates on discounting despite strong growth in Life volumes <sup>p. 18</sup>
! class="col-s" style="text-align:right" | Change
* (bar) '''NB CSM (pre-tax)''' +3% to EUR 2.2bn (FY25) from EUR 2.2bn (FY24) <sup>p. 18</sup>
|-
* '''NB CSM''' was driven by robust Savings & Protection sales, with reported growth impacted by higher interest rates for discounting of future profits <sup>p. 18</sup>
| style="text-align:left; font-weight:bold" | Total
* (bar) '''NBV (post-tax)''' stable at EUR 2.2bn (FY25) from EUR 2.3bn (FY24) <sup>p. 18</sup>
| class="col-s" style="text-align:right; font-weight:bold" | EUR 50.9bn
** '''NBV margin''': 4.5% (FY25) vs. 4.4% (FY24) <sup>p. 18</sup>
| class="col-s" style="text-align:right; font-weight:bold" | EUR 49.4bn
* '''NBV''' was broadly stable as strong growth in NB CSM balanced lower contribution from short-term multinational business in France <sup>p. 18</sup>
| class="col-s" style="text-align:right; font-weight:bold" | -2%
|-
| style="text-align:left" | Protection & Health
| class="col-s" style="text-align:right" | EUR 39.4bn
| class="col-s" style="text-align:right" | EUR 31.4bn
| class="col-s" style="text-align:right" | -4%
|-
| style="text-align:left" | Unit-Linked
| class="col-s" style="text-align:right" | EUR 8.5bn
| class="col-s" style="text-align:right" | EUR 8.5bn
| class="col-s" style="text-align:right" | +18%
|-
| style="text-align:left" | Capital-light G/A
| class="col-s" style="text-align:right" | EUR 2.0bn
| class="col-s" style="text-align:right" | EUR 7.8bn
| class="col-s" style="text-align:right" | -10%
|-
| style="text-align:left" | Traditional G/A
| class="col-s" style="text-align:right" | EUR 1.0bn
| class="col-s" style="text-align:right" | EUR 1.7bn
| class="col-s" style="text-align:right" | -10%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable"
|+ NB CSM and NBV, FY24 vs FY25 <sup>p. 18</sup>
! style="text-align:left" | Metric
! class="col-s" style="text-align:right" | FY24
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | Change
|-
| style="text-align:left" | NB CSM (pre-tax)
| class="col-s" style="text-align:right" | EUR 2.2bn
| class="col-s" style="text-align:right" | EUR 2.2bn
| class="col-s" style="text-align:right" | +3%
|-
| style="text-align:left" | NBV (post-tax)
| class="col-s" style="text-align:right" | EUR 2.3bn
| class="col-s" style="text-align:right" | EUR 2.2bn
| class="col-s" style="text-align:right" | stable
|-
| style="text-align:left" | NBV margin
| class="col-s" style="text-align:right" | 4.4%
| class="col-s" style="text-align:right" | 4.5%
| class="col-s" style="text-align:right" | —
|}
</div>
 
=== Life & Health | Growth in new business driving Normalized CSM growth ===
 
* '''Normalized CSM''' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates (change at constant scope and FX) <sup>p. 19</sup>
* (waterfall) '''Contractual Service Margin rollforward''': EUR 33.0bn (FY25) from EUR 33.6bn (FY24) <sup>p. 19</sup>
* (waterfall) '''Contractual Service Margin rollforward''':
** FY24: EUR 33.6bn <sup>p. 19</sup>
** '''New business CSM''': +EUR 2.2bn <sup>p. 19</sup>
** '''Underlying return on in-force''': +EUR 1.3bn <sup>p. 19</sup>
Line 291 ⟶ 369:
** '''Operating variance''': -EUR 0.3bn <sup>p. 19</sup>
** '''Affiliates, FX & other''': -EUR 1.4bn <sup>p. 19</sup>
** FY25: EUR 33.0bn <sup>p. 19</sup>
* '''Normalized CSM''' up by +2%, with CSM release growth reflecting better margins and new business CSM growth impacted by higher rates <sup>p. 19</sup>
* '''Economic variance''' reflecting government spreads tightening and positive equity market returns <sup>p. 19</sup>
* '''Operating variance''' driven by better margins and net flows that were more than offset by a reduction in the duration of Group Life business in Switzerland <sup>p. 19</sup>
* '''FX impact''' mainly from JPY and HKD depreciation <sup>p. 19</sup>
* '''CSM o/w Life''': FY24 EUR 25.8bn, FY25 EUR 25.4bn <sup>p. 19</sup>
* '''CSM by segment''':
** '''LifeCSM o/w Health''': FY24 EUR 257.4bn7bn, (FY25) vs. EUR 257.8bn (FY24)6bn <sup>p. 19</sup>
** '''Health''': EUR 7.6bn (FY25) vs. EUR 7.7bn (FY24) <sup>p. 19</sup>
 
=== Life & Health | Strong momentum in both short-term and long-term business ===
 
* (waterfall) '''Underlying Earnings''' +7% to EUR 3,501m (FY25)change fromat EURconstant 3,323m (FY24FX) <sup>p. 20</sup>
* (waterfall) '''Underlying Earnings''' FY24 to FY25:
** FY24: EUR 3,323m <sup>p. 20</sup>
** '''Short-term technical margin''': +EUR 60m <sup>p. 20</sup>
** '''Long-term result incl. CSM release''': +EUR 156m <sup>p. 20</sup>
** '''Financial result''': -EUR 11m <sup>p. 20</sup>
** '''Tax, FX and others''': -EUR 27m <sup>p. 20</sup>
** FY25: EUR 3,501m <sup>p. 20</sup>
* '''FY25 Underlying Earnings breakdown''':
*** '''Short-term technical margin''': EUR 479m <sup>p. 20</sup>
*** '''Long-term result incl. CSM release''': EUR 2,804m <sup>p. 20</sup>
*** '''Financial result''': EUR 946m <sup>p. 20</sup>
*** '''Tax & others''': -EUR 728m <sup>p. 20</sup>
* '''Strong short-term technical margin''' reflecting underwriting and claims initiatives that more than offset the impact of legislative change on the recoverability of value added tax in Mexico (EUR -0.1bn) <sup>p. 20</sup>
* '''Higher long-term results''' from increase in CSM release (+8%) reflecting growth in reserve base, including from favorable equity market performance, and better margins <sup>p. 20</sup>
* '''Underlying Earnings byo/w segmentLife''': FY24 EUR 2.6bn, FY25 EUR 2.7bn (+4% vs. FY24) <sup>p. 20</sup>
** '''LifeUnderlying Earnings o/w Health''': FY24 EUR 20.7bn, (FY25) EUR 0.8bn (+417% vs. FY24) vs. EUR 2.6bn (FY24) <sup>p. 20</sup>
** '''Health''': EUR 0.8bn (FY25) (+17% vs. FY24) vs. EUR 0.7bn (FY24) <sup>p. 20</sup>
 
== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ==
Line 321 ⟶ 399:
=== Growth in net income reflecting higher earnings & the gain from the sale of AXA IM ===
 
* '''Underlying earnings''' (constant FX) +6% to EUR 8.4bn (FY25) from EUR 8.1bn (FY24) <sup>p. 21</sup>
** '''Property & Casualty''': EUR 5.9bn (FY24: EUR 5.5bn, +9%) <sup>p. 21</sup>
** '''Life & Health''': EUR 3.5bn (FY24: EUR 3.3bn, +7%) <sup>p. 21</sup>
** '''Asset Management''': EUR 0.2bn (FY24: EUR 0.4bn, -57%) <sup>p. 21</sup>
** '''Holdings & other''': -EUR -1.2bn (FY24: -EUR 1.2bnstable) <sup>p. 21</sup>
* '''Net income''' (reported) +26% to EUR 9.8bn (FY24:FY25) from EUR 7.9bn (FY24) <sup>p. 21</sup>
** Includes '''capitalNon-financial gainsflows''': fromEUR AXA+2.1bn IM(FY25) disposalvs of +EUR 2-0.2bn5bn (FY24) <sup>p. 21</sup>
* (bar)** '''UnderlyingCapital earningsgains perfrom shareAXA IM disposal''': EUR 3+2.86 in2bn (FY25 (+8%) vs EUR 3.59 in FY24 <sup>p. 21</sup>
** +6% from '''earningsFinancial growthflows''' (incl. RCG): EUR -0.7bn (FY25) vs EUR +0.3bn (FY24) <sup>p. 21</sup>
** +3% from(bar) '''capitalUnderlying managementearnings per share''': EUR 3.86 (FY25) vs EUR 3.59 (FY24), +8% <sup>p. 21</sup>
** -2+6% from '''forex'''earnings growth <sup>p. 21</sup>
** +3% from capital management <sup>p. 21</sup>
** -2% from forex <sup>p. 21</sup>
*** Including -1% from temporary earnings dilution from AXA IM sale due to timing of anti-dilutive share buyback <sup>p. 21</sup>
* '''Underlying earnings''': Strongdriven by strong performance from insurance businesses <sup>p. 21</sup>
* '''Holding cost''': Stablestable, expected to remain at current level in 2026 <sup>p. 21</sup>
* '''Net income''': Mainlymainly reflecting higher underlying earnings and the gain from the sale of AXA IM <sup>p. 21</sup>
* '''Financial flows''': Lowerlower, reflecting unfavorable forex impact <sup>p. 21</sup>
 
* '''Shareholders' equity''' (Group share) <sup>p. 22</sup>
<div style="overflow-x:auto">
** '''SHE (excl. OCI)''': EUR 54.0bn (FY25) vs EUR 52.7bn (HY25) vs EUR 58.0bn (FY24) <sup>p. 22</sup>
{| class="wikitable fintable"
** '''Net OCI''': EUR -6.8bn (FY25) vs EUR -7.2bn (HY25) vs EUR -8.1bn (FY24) <sup>p. 22</sup>
! style="text-align:left" | —
** '''SHE (excl. OCI & undated subordinated debt)''': EUR 49.4bn (FY25) vs EUR 47.0bn (HY25) vs EUR 53.2bn (FY24) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY24
** '''Debt gearing''': 22.3% (FY25) vs 23.4% (HY25) vs 20.6% (FY24) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | FY25
** '''Underlying ROE''': 16.0% (FY25) vs 17.5% (HY25) vs 15.2% (FY24) <sup>p. 22</sup>
! class="col-s" style="text-align:right" | Change
* '''Opening Shareholders' equity''': EUR 49.9bn (FY24 to FY25) and EUR 45.5bn (HY25 to FY25) <sup>p. 22</sup>
|-
* '''Change in Net OCI''': EUR 1.3bn (FY24 to FY25) and EUR 0.4bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | Property& Casualty
* '''Net income for the period''': EUR 9.8bn (FY24 to FY25) and EUR 5.9bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 5.5
* '''Dividend''': EUR -4.6bn (FY24 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 5.9
* '''Annual share buyback''': EUR -1.2bn (FY24 to FY25) <sup>p. 22</sup>
| style="text-align:right" | +9%
* '''Anti-dilutive share buyback following the sale of AXA IM''': EUR -3.5bn (FY24 to FY25) and EUR -3.5bn (HY25 to FY25) <sup>p. 22</sup>
|-
* '''Undated subordinated debt''' (including interest charges): EUR -0.3bn (FY24 to FY25) and EUR -1.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:left" | Life & Health
* '''Forex''': EUR -3.5bn (FY24 to FY25) and EUR -0.1bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 3.3
* '''Other''': EUR -0.6bn (FY24 to FY25) and EUR 0.3bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | 3.5
* '''Closing Shareholders' equity''': EUR 47.2bn (FY24 to FY25) and EUR 47.2bn (HY25 to FY25) <sup>p. 22</sup>
| style="text-align:right" | +7%
|-
| style="text-align:left" | Asset Management
| style="text-align:right" | 0.4
| style="text-align:right" | 0.2
| style="text-align:right" | -57%
|-
| style="text-align:left" | Holdings & other
| style="text-align:right" | -1.2
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | '''Underlying earnings'''
| style="text-align:right" | '''8.1'''
| style="text-align:right" | '''8.4'''
| style="text-align:right" | '''+6%'''
|-
| style="text-align:left" | Non-financial flows
| style="text-align:right" | -0.5
| style="text-align:right" | +2.1
| style="text-align:right" | —
|-
| style="text-align:left; padding-left:1.5em" | o/w capital gains from AXA IM disposal
| style="text-align:right" | -
| style="text-align:right" | +2.2
| style="text-align:right" | —
|-
| style="text-align:left" | Financial flows (incl. RCG)
| style="text-align:right" | +0.3
| style="text-align:right" | -0.7
| style="text-align:right" | —
|-
| style="text-align:left" | '''Net income'''
| style="text-align:right" | '''7.9'''
| style="text-align:right" | '''9.8'''
| style="text-align:right" | '''+26%'''
|}
</div>
 
* (bar) '''Shareholders' equity¹''' (in Euro billion) <sup>p. 22</sup>
** '''SHE (excl. OCI)''': FY24 EUR 58.0bn; HY25 EUR 52.7bn; FY25 EUR 54.0bn <sup>p. 22</sup>
** '''Net OCI''': FY24 -EUR 8.1bn; HY25 -EUR 7.2bn; FY25 -EUR 6.8bn <sup>p. 22</sup>
** '''SHE (excl. OCI & undated subordinated debt)''': FY24 EUR 53.2bn; HY25 EUR 47.0bn; FY25 EUR 49.4bn <sup>p. 22</sup>
** '''Debt gearing''': FY24 20.6%; HY25 23.4%; FY25 22.3% <sup>p. 22</sup>
** '''Underlying ROE''': FY24 15.2%; HY25 17.5%; FY25 16.0% <sup>p. 22</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
! style="text-align:left" | —
! class="col-s" style="text-align:right" | FY24 to FY25
! class="col-s" style="text-align:right" | HY25 to FY25
|-
| style="text-align:left" | Opening Shareholders' equity
| style="text-align:right" | 49.9
| style="text-align:right" | 45.5
|-
| style="text-align:left" | Change in Net OCI
| style="text-align:right" | 1.3
| style="text-align:right" | 0.4
|-
| style="text-align:left" | Net income for the period
| style="text-align:right" | 9.8
| style="text-align:right" | 5.9
|-
| style="text-align:left" | Dividend
| style="text-align:right" | -4.6
| style="text-align:right" | -
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | -1.2
| style="text-align:right" | -
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | -3.5
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Undated subordinated debt (including interest charges)
| style="text-align:right" | -0.3
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Forex
| style="text-align:right" | -3.5
| style="text-align:right" | -0.1
|-
| style="text-align:left" | Other
| style="text-align:right" | -0.6
| style="text-align:right" | 0.3
|-
| style="text-align:left" | Closing Shareholders' equity
| style="text-align:right" | 47.2
| style="text-align:right" | 47.2
|}
</div>
 
== Higher organic cash remittance and robust cash position at Holding ==
Line 451 ⟶ 439:
=== Higher organic cash remittance and robust cash position at Holding ===
 
* (bar) '''Net Cash Remittance''': EUR 7.5bn (inFY25) Eurovs billionEUR 7.7bn (FY24) <sup>p. 23</sup>
** FY24 breakdown: EUR 7.7bn total, including EUR 7.1bn (ordinary cash remittance) and+ EUR 0.6bn (proceeds related to in-force treaties²) <sup>p. 23</sup>
** FY25'''Remittance ratio¹''': EUR82% (FY25) vs 82% 7.5bn(FY24) <sup>p. 23</sup>
* (circular diagram) '''RemittanceFY24 ratio¹Cash position''': 82% for FY24 and 82% forEUR FY254.0bn <sup>p. 23</sup>
* ¹ Based on ordinary'''Net cash remittance offrom EUR 7.1bn in FY24 andsubsidiaries''': +EUR 7.5bn in FY25 <sup>p. 23</sup>
* ²'''Dividend''': -EUR 04.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>
* '''Annual share buyback''': -EUR 1.2bn <sup>p. 23</sup>
 
* '''Anti-dilutive share buyback following the sale of AXA IM''': -EUR 3.5bn <sup>p. 23</sup>
<div style="overflow-x:auto">
* '''Holding costs and interest expenses''': -EUR 1.3bn <sup>p. 23</sup>
{| class="wikitable fintable"
* '''Change in net debt''': +EUR 1.6bn <sup>p. 23</sup>
! style="text-align:left" | —
* '''M&A and other''': +EUR 3.1bn <sup>p. 23</sup>
! class="col-s" style="text-align:right" | FY24 Cash position
* '''FY25 Cash position''': EUR 5.6bn <sup>p. 23</sup>
! class="col-s" style="text-align:right" | 4.0
* ¹Based on ordinary cash remittance of EUR 7.1bn in FY24 and EUR 7.5bn in FY25 <sup>p. 23</sup>.
|-
* ²EUR 0.6bn proceeds related to L&S reinsurance in-force treaties at AXA France and AXA Life Europe <sup>p. 23</sup>.
| style="text-align:left" | Net cash remittance from subsidiaries
| style="text-align:right" | —
| style="text-align:right" | +7.5
|-
| style="text-align:left" | Dividend
| style="text-align:right" | —
| style="text-align:right" | -4.6
|-
| style="text-align:left" | Annual share buyback
| style="text-align:right" | —
| style="text-align:right" | -1.2
|-
| style="text-align:left" | Anti-dilutive share buyback following the sale of AXA IM
| style="text-align:right" | —
| style="text-align:right" | -3.5
|-
| style="text-align:left" | Holding costs and interest expenses
| style="text-align:right" | —
| style="text-align:right" | -1.3
|-
| style="text-align:left" | Change in net debt
| style="text-align:right" | —
| style="text-align:right" | +1.6
|-
| style="text-align:left" | M&A and other
| style="text-align:right" | —
| style="text-align:right" | +3.1
|}
</div>
 
== Solvency II at 224% ==
Line 498 ⟶ 458:
=== Solvency II at 224% ===
 
* (waterfall) '''SolvencyEligible IIOwn ratioFunds (EOF)''': EUR 56.4bn (FY25) vs EUR 55.9bn (FY24) <sup>p. 24</sup>
** Changes: +EUR 0.2bn, +EUR 8.8bn, -EUR 0.4bn, -EUR 2.1bn, -EUR 6.0bn (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: EUR -1.25bn), -EUR 0.1bn <sup>p. 24</sup>
** FY24: 216% <sup>p. 24</sup>
** Regulatory(waterfall) &'''Solvency modelCapital changesRequirement (SCR)''': +0ptsEUR 25.2bn (FY25) vs EUR 25.9bn (FY24) <sup>p. 24</sup>
** NormalizedChanges: capitalEUR generation:0.0bn, +28ptsEUR 0.6bn, EUR 0.0bn, -EUR 1.2bn, EUR 0.0bn, -EUR 0.2bn <sup>p. 24</sup>
** Operating(waterfall) variance'''Solvency II ratio''': -1pt224% (FY25) vs 216% (FY24) <sup>p. 24</sup>
** Economic'''Regulatory & FXmodel changes''': +4pts0pts <sup>p. 24</sup>
** '''Normalized capital generation''': +28pts <sup>p. 24</sup>
** Dividend & annual share buyback: -24pts (Foreseeable dividends: EUR 4.8bn; Provision for annual Share buyback for 2026: -EUR 1.25bn) <sup>p. 24</sup>
** Management'''Operating actions, debt & othervariance''': +2pts-1pt <sup>p. 24</sup>
** FY25'''Economic & FX''': 224%+4pts <sup>p. 24</sup>
* (waterfall)* '''EligibleDividend Own& Fundsannual (EOF)share buyback''': (in Euro billion)-24pts <sup>p. 24</sup>
** FY24:'''Management EURactions, debt & other''': 55.9bn+2pts <sup>p. 24</sup>
** FY25: EUR 56.4bn <sup>p. 24</sup>
* (waterfall) '''Solvency Capital Requirement (SCR)''' (in Euro billion) <sup>p. 24</sup>
** FY24: EUR 25.9bn <sup>p. 24</sup>
** FY25: EUR 25.2bn <sup>p. 24</sup>
* (bar) '''Key sensitivities''' on Ratio as of December 31, 2025 (224%) <sup>p. 24</sup>
** '''Interest rate +50bps''': +2 pts <sup>p. 24</sup>
** '''Interest rate -50bps''': -1 pt <sup>p. 24</sup>
** '''Corporate spreads +50bps''': -1 pt <sup>p. 24</sup>
** '''Euro Sovereign spreads +50bps¹''': -7 pts <sup>p. 24</sup>
** '''Credit migration²''': -4 pts <sup>p. 24</sup>
** '''Listed Equity (excl. PE & Infra) +25%''': -1 pt <sup>p. 24</sup>
** '''Listed Equity (excl. PE & Infra) -25%''': +2 pts <sup>p. 24</sup>
** '''PE & Infra +25%''': +14 pts <sup>p. 24</sup>
** '''PE & Infra -25%''': -19 pts <sup>p. 24</sup>
** '''Inflation swap curve +50bps''': -5 pts <sup>p. 24</sup>
* ¹ Sensitivity to Euro sovereign spreads assumes a 50bps spread widening of the Euro sovereign bonds vs. the Euro swap curve (applied on sovereign and quasi-sovereign exposures) <sup>p. 24</sup>.
* ² Sensitivity to credit rating migration assumes 20% of corporate bonds (including private debt) held are downgraded by one full letter (3 notches) <sup>p. 24</sup>.
 
=== Solvency II -impact of the end of grandfathering period and Solvency II revision ===
Line 535 ⟶ 491:
** No change expected in organic capital generation <sup>p. 25</sup>
** Additional capital flexibility <sup>p. 25</sup>
* ¹ Estimated based on the Solvency Capital Requirement (SCR) and the amount of capital (EOF) under Solvency II as of January 1, 2026, as if the Solvency II revision had come into force on the same date <sup>p. 25</sup>.
 
== Thomas Buberl, Group CEO conclusion ==
Line 547 ⟶ 503:
=== Conclusion ===
 
* '''Record results''', at the top end of the target range while enhancing reserve prudence <sup>p. 27</sup>
* All businesses in excellent shape, delivering strong growth and profitability <sup>p. 27</sup>
* '''Diversified franchise''', well-positioned to capture future growth opportunities <sup>p. 27</sup>
* Laying foundations for the next plan and confident in delivering sustainable earnings growth <sup>p. 27</sup>
 
Line 556 ⟶ 512:
=== February 26, 2026 Q&A Full Year 2025 earnings ===
 
* Q&A for Full Year 2025 Earnings on February 26, 2026 <sup>p. 28</sup>
* Date: February 26, 2026 <sup>p. 28</sup>
 
=== AXA Investor Relations | Keep in touch ===
 
* '''InvestorMeet Relationsour management''' contact: +33 1 40 75 48 42 <sup>p. 29</sup>
** EmailMarch: investor.relations@axa.comRoadshows in Europe and US <sup>p. 29</sup>
** '''FollowMay us'''5: on1Q25 www.axa.comActivity Indicators in Paris <sup>p. 29</sup>
** June 2: BNP Paribas Exane CEO Conference in Paris <sup>p. 29</sup>
* (table) '''Upcoming Investor Relations Events''':
** June 2-4: Goldman Sachs European Financials Conference in Zurich <sup>p. 29</sup>
<div style="overflow-x:auto">
** July 31: HY26 Earnings Release in Paris <sup>p. 29</sup>
{| class="wikitable"
|+** September 21: AXA Investor Day in London <sup>p. 29</sup>
* '''Contact us''' <sup>p. 29</sup>
! style="text-align:left" | Date
** Investor Relations: +33 1 40 75 48 42 <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Event
** Email: investor.relations@axa.com <sup>p. 29</sup>
! class="col-m" style="text-align:right" | Location
* '''Follow us''' <sup>p. 29</sup>
|-
** Website: www.axa.com <sup>p. 29</sup>
| style="text-align:left" | March
** Social media icons for YouTube, Facebook, Instagram, Twitter, LinkedIn, and a leaf icon <sup>p. 29</sup>
| class="col-m" style="text-align:right" | Roadshows
 
| class="col-m" style="text-align:right" | Europe and US
|-
| style="text-align:left" | May 5
| class="col-m" style="text-align:right" | 1Q25 Activity Indicators
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2
| class="col-m" style="text-align:right" | BNP Paribas Exane CEO Conference
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | June 2-4
| class="col-m" style="text-align:right" | Goldman Sachs European Financials Conference
| class="col-m" style="text-align:right" | Zurich
|-
| style="text-align:left" | July 31
| class="col-m" style="text-align:right" | HY26 Earnings Release
| class="col-m" style="text-align:right" | Paris
|-
| style="text-align:left" | September 21
| class="col-m" style="text-align:right" | AXA Investor Day
| class="col-m" style="text-align:right" | London
|}
</div>
== Appendices ==
 
Line 602 ⟶ 537:
* Appendices <sup>p. 30</sup>
 
* (table of contents) Current section: '''Debt and Invested Assets''' <sup>p. 31</sup>
* Additional P&C disclosures p.36
* (table of contents) Upcoming sections: '''Additional P&C disclosures''' <sup>p. 36</sup>, '''Additional IFRS17 disclosures''' <sup>p. 41</sup>, '''Sustainability''' <sup>p. 44</sup>
* Additional IFRS17 disclosures p.41
* Sustainability p.44
 
=== Gross financial debt and maturity breakdown as of December 31st, 2025 ===
Line 611 ⟶ 548:
** '''FY25''': Total EUR 22.3bn; Tier 1 EUR 3.5bn, Tier 2 EUR 12.2bn, Senior debt EUR 4.6bn <sup>p. 32</sup>
** '''Jan 1st 2026''' (End of the grandfathering period): Total EUR 20.3bn; Tier 1 EUR 5.8bn (o/w EUR 0.4bn redeemed in Jan 2026), Tier 2 EUR 11.3bn, Senior debt EUR 3.2bn <sup>p. 32</sup>
* '''Debt gearing''': 20.6% for FY24,; 22.3% for FY25 <sup>p. 32</sup>
* (stacked bar) '''Contractual maturity breakdown''' (EUR bn):
** '''2025''': Senior debt 0.5, Tier 2 0.5, Tier 1 0.5 <sup>p. 32</sup>
<div style="overflow-x:auto">
** '''2026''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
{| class="wikitable fintable"
|+** '''2027''': Senior debt 0.5, Tier 2 0.5, Tier 1 0.5 <sup>p. 32</sup>
** '''2028''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
! style="text-align:left" | Year
** '''2029''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
! class="col-s" style="text-align:right" | Senior debt
** '''2030''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
! class="col-s" style="text-align:right" | Tier 2
** '''2031-2039''': Senior debt 0.9, Tier 2 0.9, Tier 1 0.5 <sup>p. 32</sup>
! class="col-s" style="text-align:right" | Tier 1
** '''≥2040''': Senior debt 10.8, Tier 2 0.2, Tier 1 1.4 <sup>p. 32</sup>
|-
** '''Undated''': Senior debt 4.6, Tier 2 0.7, Tier 1 0.5 <sup>p. 32</sup>
| style="text-align:left" | 2025
* '''o/w Grandfathered debt''' (Contractual maturity, EUR bn):
| style="text-align:right" | 0.5
** '''2031-2039''': Tier 1 0.7, Tier 2 0.2 <sup>p. 32</sup>
| style="text-align:right" | 0.5
** '''≥2040''': Tier 1 0.2 <sup>p. 32</sup>
| style="text-align:right" | 0.5
** '''Undated''': Tier 1 0.5 <sup>p. 32</sup>
|-
| style="text-align:left" | 2026
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2027
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2028
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2029
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2030
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.9
| style="text-align:right" | 0.9
| style="text-align:right" | 0.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | 10.8
| style="text-align:right" | 0.2
| style="text-align:right" | 1.4
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.6
| style="text-align:right" | 0.7
| style="text-align:right" | 0.5
|}
</div>
* (table) '''o/w Grandfathered debt''' (Contractual maturity, EUR bn):
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ <sup>p. 32</sup>
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
|-
| style="text-align:left" | 2025
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2026
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2027
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2028
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2029
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2030
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.7
| style="text-align:right" | 0.2
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | 0.2
| style="text-align:right" | -
|-
| style="text-align:left" | Undated
| style="text-align:right" | 0.5
| style="text-align:right" | -
|}
</div>
* (stacked bar) '''Economic maturity breakdown''' (EUR bn):
** '''2025''': Senior debt 0.1, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
<div style="overflow-x:auto">
** '''2026''': Senior debt 0.1, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
{| class="wikitable fintable"
|+** '''2027''': Senior debt 2.4, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
** '''2028''': Senior debt 2.0, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
! style="text-align:left" | Year
** '''2029''': Senior debt 0.9, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
! class="col-s" style="text-align:right" | Senior debt
** '''2030''': Senior debt 0.7, Tier 2 0.1, Tier 1 0.1 <sup>p. 32</sup>
! class="col-s" style="text-align:right" | Tier 2
** '''2031-2039''': Senior debt 6.4, Tier 2 0.2, Tier 1 1.5 <sup>p. 32</sup>
! class="col-s" style="text-align:right" | Tier 1
** '''≥2040''': Senior debt 0.5, Tier 2 0.1, Tier 1 0.7 <sup>p. 32</sup>
|-
** '''Undated''': Senior debt 4.0, Tier 2 0.1, Tier 1 0.7 <sup>p. 32</sup>
| style="text-align:left" | 2025
* '''o/w Grandfathered debt''' (Economic maturity, EUR bn):
| style="text-align:right" | 0.1
** '''2031-2039''': Tier 1 0.7, Tier 2 0.2 <sup>p. 32</sup>
| style="text-align:right" | 0.1
** '''≥2040''': Tier 1 0.2 <sup>p. 32</sup>
| style="text-align:right" | 0.1
** '''Undated''': Tier 1 0.8 <sup>p. 32</sup>
|-
* Nominal debt <sup>p. 32</sup>
| style="text-align:left" | 2026
* In January 2026, AXA has called (i) the remaining T2 GF GBP 139m due 2054 callable 2034 5.625% issued January 2014 and (ii) the T1 GF EUR 250m perpetual callable 2010 floating issued January 2005 <sup>p. 32</sup>
| style="text-align:right" | 0.1
* Economic maturity takes into account the first date of step up calls on institutionally placed subordinated debt <sup>p. 32</sup>
| style="text-align:right" | 0.1
* For Solvency 2 RT1 debt, which has no step-up, the undated nature of the instrument is retained for the purpose of this diagram <sup>p. 32</sup>
| style="text-align:right" | 0.1
* This should not be construed, nor relied upon, as an indication that the instrument will not be called for redemption when callable <sup>p. 32</sup>
|-
* Such decision will depend on several factors, including capital and liquidity position and refinancing economics at the prevailing time <sup>p. 32</sup>
| style="text-align:left" | 2027
| style="text-align:right" | 2.4
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2028
| style="text-align:right" | 2.0
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2029
| style="text-align:right" | 0.9
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2030
| style="text-align:right" | 0.7
| style="text-align:right" | 0.1
| style="text-align:right" | 0.1
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 6.4
| style="text-align:right" | 0.2
| style="text-align:right" | 1.5
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | 0.5
| style="text-align:right" | 0.1
| style="text-align:right" | 0.7
|-
| style="text-align:left" | Undated
| style="text-align:right" | 4.0
| style="text-align:right" | 0.1
| style="text-align:right" | 0.7
|}
</div>
* (table) '''o/w Grandfathered debt''' (Economic maturity, EUR bn):
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ <sup>p. 32</sup>
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | Tier 1
! class="col-s" style="text-align:right" | Tier 2
|-
| style="text-align:left" | 2025
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2026
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2027
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2028
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2029
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2030
| style="text-align:right" | -
| style="text-align:right" | -
|-
| style="text-align:left" | 2031-2039
| style="text-align:right" | 0.7
| style="text-align:right" | 0.2
|-
| style="text-align:left" | ≥2040
| style="text-align:right" | 0.2
| style="text-align:right" | -
|-
| style="text-align:left" | Undated
| style="text-align:right" | 0.8
| style="text-align:right" | -
|}
</div>
* '''Nominal debt''' <sup>p. 32</sup>
* In January 2026, AXA called the remaining T2 GF GBP 139m due 2054 callable 2034 5.625% (issued January 2014) and the T1 GF EUR 250m perpetual callable 2010 floating (issued January 2005) <sup>p. 32</sup>
* '''Economic maturity''' takes into account the first date of step-up calls on institutionally placed subordinated debt <sup>p. 32</sup>
* For Solvency 2 RT1 debt, which has no step-up, the undated nature of the instrument is retained for this diagram <sup>p. 32</sup>
* This should not be construed as an indication that the instrument will not be called for redemption when callable; decision depends on capital, liquidity, and refinancing economics <sup>p. 32</sup>
 
=== General Account invested assets ===
Line 828 ⟶ 594:
** '''Cash''': 4% <sup>p. 33</sup>
** '''Policy loans''': 0% <sup>p. 33</sup>
* '''Invested assets''' (100%) in EUR bn (FY25):
** '''Fixed income''': EUR 345bn (77%) <sup>p. 33</sup>
*** o/w '''Government bonds''': EUR 167bn (37%) <sup>p. 33</sup>
*** o/w '''Corporate bonds and loans''': EUR 121bn (27%) <sup>p. 33</sup>
*** o/w '''Other fixed income'''¹: EUR 56bn (13%) <sup>p. 33</sup>
** '''Real estate''': EUR 41bn (9%) <sup>p. 33</sup>
** '''Infrastructure equity''': EUR 10bn (2%) <sup>p. 33</sup>
** '''Listed equities'''²: EUR 10bn (2%) <sup>p. 33</sup>
** '''Private equity and hedge funds'''³: EUR 23bn (5%) <sup>p. 33</sup>
** '''Cash''': EUR 19bn (4%) <sup>p. 33</sup>
** '''Policy loans''': EUR 2bn (0%) <sup>p. 33</sup>
** '''Total Insurance Invested Assets'''⁴: EUR 450bn (100%) <sup>p. 33</sup>
* '''Duration gap''': -0.4 year <sup>p. 33</sup>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ <sup>p. 33</sup>
! style="text-align:left" | Invested assets (100%) In Euro billion
! class="col-s" style="text-align:right" | FY25
! class="col-s" style="text-align:right" | %
|-
| style="text-align:left" | '''Fixed income'''
| style="text-align:right" | 345
| style="text-align:right" | 77%
|-
| style="text-align:left; padding-left:1.5em" | o/w Government bonds
| style="text-align:right" | 167
| style="text-align:right" | 37%
|-
| style="text-align:left; padding-left:1.5em" | o/w Corporate bonds and loans
| style="text-align:right" | 121
| style="text-align:right" | 27%
|-
| style="text-align:left; padding-left:1.5em" | o/w Other fixed income
| style="text-align:right" | 56
| style="text-align:right" | 13%
|-
| style="text-align:left" | '''Real estate'''
| style="text-align:right" | 41
| style="text-align:right" | 9%
|-
| style="text-align:left" | '''Infrastructure equity'''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | '''Listed equities'''
| style="text-align:right" | 10
| style="text-align:right" | 2%
|-
| style="text-align:left" | '''Private equity and hedge funds'''
| style="text-align:right" | 23
| style="text-align:right" | 5%
|-
| style="text-align:left" | '''Cash'''
| style="text-align:right" | 19
| style="text-align:right" | 4%
|-
| style="text-align:left" | '''Policy loans'''
| style="text-align:right" | 2
| style="text-align:right" | 0%
|-
| style="text-align:left" | '''Total Insurance Invested Assets'''
| style="text-align:right" | 450
| style="text-align:right" | 100%
|}
</div>
* ¹ '''Other fixed income''' includes Asset Backed Securities (EUR 25bn), Residential Loans (EUR 16bn), Commercial & Agricultural Loans (EUR 7bn) and Agency Pools (EUR 8bn) <sup>p. 33</sup>
* ² '''Listed equities''' includes hedges; listedListed equities excluding hedges at EUR 14bn <sup>p. 33</sup>
* ³ '''Private equity and hedge funds''' includes Private Equity (EUR 17bn), Hedge Funds (EUR 5bn) and Non-listed Equities (EUR 1bn) <sup>p. 33</sup>
* ⁴ ReferPlease refer to the financial supplement for more details <sup>p. 33</sup>
 
=== Structured and Private Credit assets ===
 
* '''Invested assets''' (100%) in EUR bn (FY25):
<div style="overflow-x:auto">
** '''Residential Mortgages''': EUR 16bn (4% of G/A portfolio) <sup>p. 34</sup>
{| class="wikitable fintable"
|+*** EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 34</sup>
*** EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 34</sup>
! style="text-align:left" | Invested assets (100%) In Euro billion
** '''CLO & ABS''': EUR 25bn (6% of G/A portfolio) <sup>p. 34</sup>
! class="col-s" style="text-align:right" | FY25
*** 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 34</sup>
! class="col-s" style="text-align:right" | % of total G/A¹ portfolio
** '''Infrastructure debt''': EUR 8bn (2% of G/A portfolio) <sup>p. 34</sup>
! class="col-m" style="text-align:right" | Comments
*** Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 34</sup>
|-
** '''CRE debt''': EUR 8bn (2% of G/A portfolio) <sup>p. 34</sup>
| style="text-align:left" | '''Residential Mortgages'''
*** Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 34</sup>
| style="text-align:right" | 16
** '''Mid-Market lending''': EUR 10bn (2% of G/A portfolio) <sup>p. 34</sup>
| style="text-align:right" | 4%
*** Strong diversification with EUR 8m average ticket <sup>p. 34</sup>
| style="text-align:right" | - EUR 6bn Dutch mortgages, NHG guaranteed - EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
*** Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 34</sup>
|-
** '''Other''': EUR 2bn (0% of G/A portfolio) <sup>p. 34</sup>
| style="text-align:left" | '''CLO & ABS'''
** '''Total Structured and Private Credit Assets''': EUR 69bn (15% of G/A portfolio) <sup>p. 34</sup>
| style="text-align:right" | 25
*** o/w 54% participating <sup>p. 34</sup>
| style="text-align:right" | 6%
* G/A: General Account <sup>p. 34</sup>
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 93% rated AAA-AA)
|-
| style="text-align:left" | '''Infrastructure debt'''
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | '''CRE debt'''
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | '''Mid-Market lending'''
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with EUR 8m average ticket - Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | '''Other'''
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left" | '''Total Structured and Private Credit Assets'''
| style="text-align:right" | 69
| style="text-align:right" | 15%
| style="text-align:right" | o/w 54% participating
|}
</div>
* ¹ G/A: General Account <sup>p. 34</sup>
 
=== Investment portfolio | Fixed Income reinvestment ===
 
* (donut) '''FY25 Fixed Income Reinvestment''': EUR 57bn <sup>p. 35</sup>
** '''Government bonds & related''' ¹: 32% (Average rating: AA) <sup>p. 35</sup>
** '''Investment grade credit''': 40% (Average rating: A) <sup>p. 35</sup>
** '''ABS/CLO/IG fund financing''': 21% <sup>p. 35</sup>
** '''Below investment grade credit''': 7% <sup>p. 35</sup>
* (bar) '''FY25 Fixed Income Reinvestment Yield''':
** '''Public fixed income''' ¹: 3.5% <sup>p. 35</sup>
** '''Private & Structured fixed income''' ²: 4.7% <sup>p. 35</sup>
** '''Total fixed income''': 3.9% <sup>p. 35</sup>
* EUR 57bn '''Euro 57 billion fixed income invested''' at 3.9%''' <sup>p. 35</sup>
** Average duration of 9 years <sup>p. 35</sup>
** Includes EUR 19.7bn of '''Private & Structured Credit''' invested at 4.7% (CLOs, ABS, Infra & CRE debt, Fund financing and Private HY) <sup>p. 35</sup>
** Gradual shift from alternative total return assets to Private & Structured credit <sup>p. 35</sup>
* ¹ '''Government andbonds Corporate& bondsrelated''' refers to Government and Corporate bonds and related <sup>p. 35</sup>
* ² '''Private & Structured creditfixed income''' refers to Private & Structured credit (CLOs, ABS, Infra & CRE debt, Fund financing and Private hybrid) <sup>p. 35</sup>
 
* '''Table of contents''':
* (table of contents) Current section: '''Additional P&C disclosures''' <sup>p. 36</sup>
** Other sections:1. Debt and Invested Assets, <sup>p. 31</sup>, Additional IFRS17 disclosures <sup>p. 41</sup>, Sustainability <sup>p. 4436</sup>
** 2. Additional P&C disclosures, p.36 <sup>p. 36</sup>
** 3. Additional IFRS17 disclosures, p.41 <sup>p. 36</sup>
** 4. Sustainability, p.44 <sup>p. 36</sup>
 
=== AXA XL Insurance | Large Commercial & Specialty business ===
Line 969 ⟶ 669:
*** UK & Lloyds: 19% <sup>p. 37</sup>
* Leading market positions across lines <sup>p. 37</sup>
** Top 3 globally in Multinational Programs <sup>p. 37</sup>
*** TopMultinational 3Programs globally(Source: in MarineMcKinsey) <sup>p. 37</sup>
*** TopMarine 3(Source: globallyAon, inGuy FineCarpenter, Artand &Global SpecieMarket Insights) <sup>p. 37</sup>
*** Fine Art & Specie (Source: Industry Research Biz (January 2026)) <sup>p. 37</sup>
* Managing the cycle to deliver consistent profitability <sup>p. 37</sup>
** (scatter plot) '''Profitability vs. Ex-price growth''':
** (scatter plot) '''Profitability vs. Ex-price growth''': Property (high profitability, high ex-price growth), Specialty (mid-high profitability, mid-high ex-price growth), Casualty (mid-low profitability, mid-low ex-price growth), Professional lines (low profitability, low ex-price growth) <sup>p. 37</sup>
*** Property (top right) <sup>p. 37</sup>
*** Specialty (middle right) <sup>p. 37</sup>
*** Casualty (middle left) <sup>p. 37</sup>
*** Professional lines (bottom left) <sup>p. 37</sup>
 
=== P&C | Focus on Reserves ===
 
<div style="overflow-x:auto">
* (bar chart) '''Claims reserves ratio''' (Net undiscounted claims reserves/Net earned premiums) <sup>p. 38</sup>
{| class="wikitable fintable"
** IFRS4: FY18 179%, FY19 185%, FY20 193%, FY21 188%, FY22 189% <sup>p. 38</sup>
**|+ IFRS17:Claims FY22reserves 198%,ratio FY23(Net 195%,undiscounted FY24claims 180%,reserves/Net FY25earned 175%premiums) <sup>p. 38</sup>
! style="text-align:left" | Year
* (bar chart) '''Technical reserves ratio''' (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup>
! class="col-s" style="text-align:right" | IFRS4
** IFRS4: FY18 213%, FY19 227%, FY20 233%, FY21 226%, FY22 227% <sup>p. 38</sup>
! class="col-s" style="text-align:right" | IFRS17
** IFRS17: FY22 234%, FY23 232%, FY24 216%, FY25 210% <sup>p. 38</sup>
|-
* Technical reserves include net undiscounted claims reserves and unearned premium reserves <sup>p. 38</sup>.
| style="text-align:left" | FY18
| style="text-align:right" | 179%
| style="text-align:right" | —
|-
| style="text-align:left" | FY19
| style="text-align:right" | 185%
| style="text-align:right" | —
|-
| style="text-align:left" | FY20
| style="text-align:right" | 193%
| style="text-align:right" | —
|-
| style="text-align:left" | FY21
| style="text-align:right" | 188%
| style="text-align:right" | —
|-
| style="text-align:left" | FY22
| style="text-align:right" | 189%
| style="text-align:right" | 198%
|-
| style="text-align:left" | FY23
| style="text-align:right" | —
| style="text-align:right" | 195%
|-
| style="text-align:left" | FY24
| style="text-align:right" | —
| style="text-align:right" | 180%
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | 175%
|}
</div>
 
<div style="overflow-x:auto">
{| class="wikitable fintable"
|+ Technical reserves ratio (Net undiscounted technical reserves /Net earned premiums) <sup>p. 38</sup>
! style="text-align:left" | Year
! class="col-s" style="text-align:right" | IFRS4
! class="col-s" style="text-align:right" | IFRS17
|-
| style="text-align:left" | FY18
| style="text-align:right" | 213%
| style="text-align:right" | —
|-
| style="text-align:left" | FY19
| style="text-align:right" | 227%
| style="text-align:right" | —
|-
| style="text-align:left" | FY20
| style="text-align:right" | 233%
| style="text-align:right" | —
|-
| style="text-align:left" | FY21
| style="text-align:right" | 226%
| style="text-align:right" | —
|-
| style="text-align:left" | FY22
| style="text-align:right" | 227%
| style="text-align:right" | 234%
|-
| style="text-align:left" | FY23
| style="text-align:right" | —
| style="text-align:right" | 232%
|-
| style="text-align:left" | FY24
| style="text-align:right" | —
| style="text-align:right" | 216%
|-
| style="text-align:left" | FY25
| style="text-align:right" | —
| style="text-align:right" | 210%
|}
</div>
 
=== P&C | 2026 Simplified Group Nat Cat Reinsurance Program 1 ===
 
* Stable retention levels maintained in 2026 as in 2025 <sup>p. 39</sup>
* (bar chart) '''Insurance segment (occurrence protection)''' in Euro <sup>p. 39</sup>:
** '''EU Windstorm''': Capacity EUR 4.0bn, Retention EUR 600m <sup>p. 39</sup>
** '''Europe Flood''': Capacity EUR 2.1bn, Retention EUR 450m <sup>p. 39</sup>
Line 995 ⟶ 774:
** '''NA Earthquake''': Capacity EUR 1.2bn, Retention EUR 600m <sup>p. 39</sup>
** '''Per other perils''': Capacity [unclear, visually around EUR 0.8bn], Retention EUR 400m <sup>p. 39</sup>
*** Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake as well as a series of other secondary perils <sup>p. 39</sup>
* Reinsurance segment (illustrative) includes Alternative Capital & Cat Bonds <sup>p. 39</sup>
*** ProgramCapacity excludesvaries localby reinsuranceperil coverstype <sup>p. 39</sup>
* (diagram) '''Reinsurance segment (illustrative)''': Alternative Capital & Cat Bonds <sup>p. 39</sup>
* Excludes local reinsurance covers <sup>p. 39</sup>
* Varying retention between MX and NA (EUR 400m MX, EUR 600m NA) <sup>p. 39</sup>
* Other perils include Turkey earthquake, Other Europe and NA perils, South America Earthquake, as well as a series of other secondary perils, with capacity varying by peril type <sup>p. 39</sup>
 
=== P&C | AXA Group earnings deviation with different levels of Nat Cat cost 1 in 2026 ===
 
* (bar chart) '''Group underlying earnings deviation''' to average Nat Cat charges in 2026''' net of reinsurance, post-tax (in Euro billion) <sup>p. 40</sup>
** (bar) '''More severe years - Negative deviation in ca. 40% of cases (More severe years)''':
*** 1/20y (95th percentile): -EUR 1.2bn <sup>p. 40</sup>
*** 1/10y (90th percentile): -EUR 0.8bn <sup>p. 40</sup>
*** 1/5y (80th percentile): -EUR 0.4bn <sup>p. 40</sup>
** (bar) '''Median (50th percentile)''': EUR 0.1bn <sup>p. 40</sup>
** (bar) '''Less severe years - Positive deviation in ca. 60% of cases (Less severe years)''':
*** 1/5y (20th percentile): EUR 0.5bn <sup>p. 40</sup>
*** 1/10y (10th percentile): EUR 0.7bn <sup>p. 40</sup>
*** 1/20y (5th percentile): EUR 0.8bn <sup>p. 40</sup>
* (bar chart) '''Average Expected Nat Cat charges''' net of reinsurance, pre-tax (in Euro billion) <sup>p. 40</sup>
** (bar) '''2025''': EUR 2.6bn,; Estimated impact on GEP ca. 4.5% <sup>p. 40</sup>
** (bar) '''2026''': EUR 2.7bn,; Estimated impact on GEP ca. 4.5% <sup>p. 40</sup>
* Natural catastrophe cost is defined as Aggregate Exceedance Probability (AEP) of all natural perils worldwide, net of tax and reinsurance <sup>p. 40</sup>
* Deviation is compared to a normalized level, which are costs associated with natural catastrophes expected in an average year (ca. 4.5 points of estimated FY25 GEP, undiscounted and net of reinsurance) <sup>p. 40</sup>
 
* (table1. ofDebt contents)and '''AdditionalInvested IFRS17 disclosures''' on p.41Assets <sup>p. 4131</sup>
* (table2. ofAdditional contents)P&C Debt and Invested Assets on p.31disclosures <sup>p. 4136</sup>
* (table of contents)3. Additional P&CIFRS17 disclosures on p.36 <sup>p. 41</sup>
* (table of contents)4. Sustainability on p.44 <sup>p. 4144</sup>
 
=== P&C | Margin analysis ===
 
* (flow) '''UnderlyingTechnical EarningsResult''' FY25:(in EUR 5million,872m; Change: +EUR 501m; Growth vs. FY24 (at constant FXpre-tax): +9% <sup>p. 42</sup>
** '''UnderlyingCurrent EarningsAccident beforeYear taxUndiscounted Technical Margin''' FY25: EUR 82,040m;778 Change(change: +EUR 681m707) <sup>p. 42</sup>
*** '''TaxGross Earned Premiums''': EUR -257,060m; Change: -EUR656 169m(+6%) <sup>p. 42</sup>
*** '''Affiliates,Current MinorityAccident interestsYear &Undiscounted OtherCombined Ratio''': EUR95.2% (-108m; Change: -EUR 10m1.0pt) <sup>p. 42</sup>
*** '''Technicalo/w ResultNat Cats''': 3.4% (In Euro million, pre-tax0.4pt) <sup>p. 42</sup>
** '''Current Accident Year Undiscounted Technical MarginDiscounting''' FY25: EUR 2,778m;009 Change(change: +EUR 707m115) <sup>p. 42</sup>
*** '''GrossDiscounting Earned PremiumsRatio''': EUR(in 57,656m,Combined +6Ratio points): -3.5% (+0.0pt) <sup>p. 42</sup>
*** '''Current Accident Year Undiscounted Combined Ratio''': 95.2%, -1.0pt <sup>p. 42</sup>
*** '''o/w Nat Cats''': 3.4%, -0.4pt <sup>p. 42</sup>
** '''Current Accident Year Discounting''' FY25: EUR 2,009m; Change: +EUR 115m <sup>p. 42</sup>
*** '''Discounting Ratio''' (in Combined Ratio points): -3.5%, +0.0pt <sup>p. 42</sup>
*** '''Current Accident Year Net Claims reserves''': EUR 19.0bn <sup>p. 42</sup>
*** '''Duration''': 4.0 years <sup>p. 42</sup>
*** '''Current Accident Year Discount Rate''': 2.8% <sup>p. 42</sup>
** '''Prior Years' Reserve Development (PYD)''' FY25: EUR 622m;622 Change(change: -EUR 341m341) <sup>p. 42</sup>
*** '''PYD ratio''': -1.1%, (+0.7pt) <sup>p. 42</sup>
** '''Sensitivity to Current Accident Year discount rate changes''' <sup>p. 42</sup>
*** +25bps: +EUR 0.2bn <sup>p. 42</sup>
*** -25bps: -EUR 0.2bn <sup>p. 42</sup>
* (flow) '''Financial Result''' (Inin EuroEUR million, pre-tax) <sup>p. 42</sup>
** '''Investment Income''' FY25: EUR 3,988m;988 Change(change: +EUR 435m435) <sup>p. 42</sup>
*** '''FY25 Average Assets''': EUR 115bn <sup>p. 42</sup>
*** '''Asset book yield''': 3.5% <sup>p. 42</sup>
*** '''FY25 Reinvestment yield¹'''¹: 4.3% <sup>p. 42</sup>
** '''Insurance Finance Expenses''' FY25: -EUR -1,358m;358 Change(change: -EUR 235m235) <sup>p. 42</sup>
*** '''FY24 Reserves at locked-in rate''': EUR 71bn <sup>p. 42</sup>
*** '''Liability book yield''': 1.9% <sup>p. 42</sup>
** '''2025 Insurance Finance Expenses''' (pre-tax)''': ~EUR -1.4bn <sup>p. 42</sup>
** '''Sensitivity of 2025e Insurance Finance Expenses to changes in 2025 current AY Discount''' <sup>p. 42</sup>
*** +25bps: ~EUR -50m <sup>p. 42</sup>
*** -25bps: ~EUR +50m <sup>p. 42</sup>
* (flow) '''Underlying Earnings before tax''': EUR 8,040 (change: +EUR 681) <sup>p. 42</sup>
* (flow) '''Technical Result''' components (Current Accident Year Undiscounted Technical Margin, Current Accident Year Discounting, Prior Years' Reserve Development) and '''Financial Result''' components (Investment Income, Insurance Finance Expenses) sum up to '''Underlying Earnings before tax''' <sup>p. 42</sup>
** Changes'''Tax''': versus-EUR FY242,060 at(change: constant-EUR FX169) <sup>p. 42</sup>
** Reinvestment'''Affiliates, yield¹Minority oninterests fixed& incomeOther''': assets-EUR 108 (change: -EUR 10) <sup>p. 42</sup>
** '''Underlying Earnings''': EUR 5,872 (change: +EUR 501) <sup>p. 42</sup>
* Parallel shift of the full-year average yield curve (average of monthly opening discount rates of 2025) used for discounting FY25 current accident year net reserve <sup>p. 42</sup>
*** '''Growth vs. FY24''' (at constant FX): +9% <sup>p. 42</sup>
 
=== L&H | Margin analysis ===
 
* Includes scope impact <sup>p. 43</sup>
* (flow) '''UnderlyingTechnical EarningsResult''' FY25:(in EUR 3million,501m; Change: +EUR 219m; Growth vs. FY24 (at constant FXpre-tax): +7% <sup>p. 43</sup>
** '''UnderlyingShort-term EarningsTechnical before taxMargin''' FY25: EUR 4,229m;479 Change(change: +EUR 205m60) <sup>p. 43</sup>
*** '''Tax''':Includes EURrecapture -800m;of Change: +EUR 65mLaya <sup>p. 43</sup>
*** '''Affiliates,Gross MinorityEarned interests & OtherPremiums''': EUR 72m; Change: -EUR17,416 51m(+10%) <sup>p. 43</sup>
*** '''TechnicalAll ResultYear Combined Ratio''': (In97.2% Euro million, pre(-tax0.1pts) <sup>p. 43</sup>
** '''ShortLong-term Technical Margin''' FY25: EUR 479m;2,804 Change(change: +EUR 60m156) <sup>p. 43</sup>
*** '''GrossCSM Earned Premiumsrelease''': EUR 17,416m2,954 (+10%EUR 215) <sup>p. 43</sup>
*** '''AllTechnical Year Combined Ratioexperience''': 97.2%,-EUR 150 (-0.1ptsEUR 58) <sup>p. 43</sup>
*** Incl.'''Life recapture& ofHealth LayaFY25 CSM Key Sensitivities''' (in EUR billion) <sup>p. 43</sup>
** '''Long-term Technical Margin''' FY25: EUR 2,804m; Change: +EUR 156m <sup>p. 43</sup>
*** '''CSM release''': EUR 2,954m, +EUR 215m <sup>p. 43</sup>
*** '''Technical experience''': EUR -150m, -EUR 58m <sup>p. 43</sup>
** '''Life & Health FY25 CSM Key Sensitivities''' (in Euro billion) <sup>p. 43</sup>
*** '''Baseline''': 33.3 <sup>p. 43</sup>
*** '''Interest rates +50bps''' +50bps: -0.8 <sup>p. 43</sup>
*** '''Interest rates -50bps''' -50bps: 0.6 <sup>p. 43</sup>
*** '''Sovereign spreads +50bps''' +50bps: -1.9 <sup>p. 43</sup>
*** '''Sovereign spreads -50bps''' -50bps: 1.9 <sup>p. 43</sup>
*** '''Corporate spread +50bps''' +50bps: -0.8 <sup>p. 43</sup>
*** '''Corporate spread -50bps''' -50bps: 0.8 <sup>p. 43</sup>
*** '''Equities''' +25%''': 1.8 <sup>p. 43</sup>
*** '''Equities''' -25%''': -2.2 <sup>p. 43</sup>
* (flow) '''Financial Result''' (Inin EuroEUR million, pre-tax) <sup>p. 43</sup>
** '''Investment Income''' (non-VFA only)''' FY25: EUR 2,484m;484 Change(change: -EUR 1m1) <sup>p. 43</sup>
*** '''FY25 Average Assets''': EUR 98bn <sup>p. 43</sup>
*** '''Asset book yield''': 2.5% <sup>p. 43</sup>
*** '''FY25 Reinvestment yield¹'''¹: 3.8% <sup>p. 43</sup>
** '''Insurance Finance Expenses''' (non-VFA only)''' FY25: -EUR -1,538m;538 Change(change: -EUR 9m9) <sup>p. 43</sup>
*** '''FY24 Reserves at locked-in rate''': EUR 62bn <sup>p. 43</sup>
*** '''Liability book yield''': 2.5% <sup>p. 43</sup>
* (flow) '''Underlying Earnings before tax''': EUR 4,229 (change: +EUR 205) <sup>p. 43</sup>
* (flow) '''Short-term Technical Margin''', '''Long-term Technical Margin''', '''Investment Income (non-VFA only)''', and '''Insurance Finance Expenses (non-VFA only)''' sum up to '''Underlying Earnings before tax''' <sup>p. 43</sup>
** Changes'''Tax''': versus-EUR FY24800 at(change: constant+EUR FX65) <sup>p. 43</sup>
** Reinvestment'''Affiliates, yield¹Minority oninterests fixed& incomeOther''': assetsEUR 72 (change: -EUR 51) <sup>p. 43</sup>
** '''Underlying Earnings''': EUR 3,501 (change: +EUR 219) <sup>p. 43</sup>
 
*** '''Growth vs. FY24''' (at constant FX): +7% <sup>p. 43</sup>
<div style="overflow-x:auto">
* '''Invested assets''' (100%) (in EUR billion) <sup>p. 43</sup>
{| class="wikitable fintable"
** '''Residential Mortgages''': EUR 16 (4% of total G/A portfolio) <sup>p. 43</sup>
! style="text-align:left" | Invested assets (100%) In Euro billion
*** EUR 6bn Dutch mortgages, NHG guaranteed <sup>p. 43</sup>
! class="col-s" style="text-align:right" | FY25
*** EUR 10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV) <sup>p. 43</sup>
! class="col-s" style="text-align:right" | %oftotal G/A portfolio
** '''CLO & ABS''': EUR 25 (6% of total G/A portfolio) <sup>p. 43</sup>
! class="col-m" style="text-align:right" | Comments
*** 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA) <sup>p. 43</sup>
|-
** '''Infrastructure debt''': EUR 8 (2% of total G/A portfolio) <sup>p. 43</sup>
| style="text-align:left" | Residential Mortgages
*** Skewed towards resilient industries (Telecom, Utilities, Transport) <sup>p. 43</sup>
| style="text-align:right" | 16
** '''CRE debt''': EUR 8 (2% of total G/A portfolio) <sup>p. 43</sup>
| style="text-align:right" | 4%
*** Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV <sup>p. 43</sup>
| style="text-align:right" | - €6bn Dutch mortgages, NHG guaranteed - €10bn self originated mortgages in Switzerland (56% LTV) and Germany (45% LTV)
** '''Mid-Market lending''': EUR 10 (2% of total G/A portfolio) <sup>p. 43</sup>
|-
*** Strong diversification with EUR 8m average ticket <sup>p. 43</sup>
| style="text-align:left" | CLO&ABS
*** Investments through SMAs with strict underwriting guidelines: senior secured, covenants, restrictions on asset sales and sector allocation <sup>p. 43</sup>
| style="text-align:right" | 25
** '''Other''': EUR 2 (0% of total G/A portfolio) <sup>p. 43</sup>
| style="text-align:right" | 6%
** '''Total Structured and Private Credit Assets''': EUR 69 (15% of total G/A portfolio) <sup>p. 43</sup>
| style="text-align:right" | - 91% senior CLOs with circa 40% subordination (100% rated AAA-A and 92% rated AAA-AA)
*** o/w 54% participating <sup>p. 43</sup>
|-
| style="text-align:left" | Infrastructure debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Skewed towards resilient industries (Telecom, Utilities, Transport)
|-
| style="text-align:left" | CRE debt
| style="text-align:right" | 8
| style="text-align:right" | 2%
| style="text-align:right" | - Strong sector diversification (mainly logistics, residential and retail), mostly in Europe, and circa 60% LTV
|-
| style="text-align:left" | Mid-Market lending
| style="text-align:right" | 10
| style="text-align:right" | 2%
| style="text-align:right" | - Strong diversification with €8m average ticket - Investments through SMAs with strict underwriting guidelines : senior secured, covenants, restrictions on asset sales and sector allocation
|-
| style="text-align:left" | Other
| style="text-align:right" | 2
| style="text-align:right" | 0%
| style="text-align:right" | —
|-
| style="text-align:left; font-weight:bold" | Total Structured and Private Credit Assets
| style="text-align:right; font-weight:bold" | 69
| style="text-align:right; font-weight:bold" | 15%
| style="text-align:right; font-weight:bold" | o/w 54% participating
|}
</div>
 
* (table of contents) '''Sustainability''' on p.44 <sup>p. 44</sup>
* (table of contents) Debt and Invested Assets on p.31 <sup>p. 44</sup>
* (table of contents) Additional P&C disclosures on p.36 <sup>p. 44</sup>
* (table of contents) Additional IFRS17 disclosures on p.41 <sup>p. 44</sup>
 
=== Expanding AXA's role in society: AXA for Progress Index 1 ===
Line 1,157 ⟶ 899:
** '''Target''': EUR 6bn³ in P&C GWP to support transition underwriting (cumulative 2024-2026) <sup>p. 45</sup>
** '''2025 Result''': EUR 4.6bn <sup>p. 45</sup>
** '''Target''': >20,000⁴ climate adaptation solutions & services (cumulative 2024-2026); Target revised in 2025 <sup>p. 45</sup>
*** Target revised in 2025 <sup>p. 45</sup>
** '''2025 Result''': 19,698 Cumulative 2024-2025 <sup>p. 45</sup>
** '''Target''': >20m⁵ inclusive insurance customers by 2026 <sup>p. 45</sup>
Line 1,168 ⟶ 911:
** '''Target''': 50% Percentage of AXA Group employees engaged in volunteering activities by 2026 <sup>p. 45</sup>
** '''2025 Result''': 56% <sup>p. 45</sup>
* Footnote 7: Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030. <sup>p. 45</sup>
* AXA's Sustainability Statement is subject to completion of a certification with limited assurance by AXA Group's auditors and will be presented to the AXA Board of Directors for approval on March 11, 2026 <sup>p. 45</sup>
* Footnote 8: Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage). <sup>p. 45</sup>
* Scope²: Corporate and sovereign debt, real estate and private assets. Timeframe: per annum through 2026 <sup>p. 45</sup>
* Scope³: AXA XL, AXA Climate, AXA France, AXA Spain, AXA Germany, AXA Switzerland, AXA Hong Kong, AXA Mexico, and AXA XL. Gross Written Premiums (GWP). Timeframe: cumulative 2024-2026 <sup>p. 45</sup>
* Scope⁴: Commercial lines portfolio of AXA France, AXA Germany, AXA Switzerland, AXA UK, AXA Belgium, AXA Hong Kong, AXA Mexico, and AXA XL. Climate solutions & services include (i) training/education, (ii) risk assessment/awareness, (iii) gap analysis, (iv) prevention/adaptation solution, and/or (v) crisis management/remediation response. Timeframe: cumulative 2024-2026. Following strong support within the Group for climate adaptation solutions & services in 2024 and 2025, AXA is proposing a significant increase in its target for the 2024-2026 period, from >9,000 to >20,000 <sup>p. 45</sup>
* Scope⁵: Refers to affordable and adapted insurance for emerging markets and modest income segments in mature markets <sup>p. 45</sup>
* Number of employees who have been trained on climate change adaptation, comprising a training under the AXA Sustainability Academy. Timeframe: cumulative 2024-2026 <sup>p. 45</sup>
* Variation of AXA Group absolute carbon emissions (scope: energy Scopes 1 and 2, car fleet and business travel). Timeframe: 2019-2030 <sup>p. 45</sup>
* Carbon credits from projects that focus on capturing and storing carbon emissions from the atmosphere using nature-based or technical solutions (e.g. restorative agriculture, forest restoration or carbon capture and storage) <sup>p. 45</sup>
 
=== Sustainability Performance & Ratings ===
 
* '''S&P Global''':
** '''2025 percentile''': 97th in Dow Jones Best-in-Class Europe & World indices <sup>p. 46</sup>
** '''2025 ESG Risk Rating''': 17.0 - Low risk <sup>p. 46</sup>
* '''MSCI''':
** '''2025 score''': AAA <sup>p. 46</sup>
* '''CDPMSCI''':
** '''2025 score''': AAA <sup>p. 46</sup>
* '''CDP'''
** '''2025 score''': B <sup>p. 46</sup>
* '''Morningstar Sustainalytics''':
** '''2025 ESG Risk Rating''': 17.0 - Low risk <sup>p. 46</sup>
* '''FTSE Russell''':
** '''2025 score''': 4.3/5 in FTSE4Good Index Series <sup>p. 46</sup>
* The CSA ranking is a key performance indicator for AXA Group, used to calculate the grant of Long-Term Incentives (more precisely AXA Restricted Shares) <sup>p. 46</sup>.
Line 1,199 ⟶ 936:
* '''AXA XL''': includes insurance and reinsurance activities and holding <sup>p. 47</sup>.
* '''Asia, Africa & EME-LATAM''': <sup>p. 47</sup>
** '''Asia''': Japan (insurance activities and holding), Hong Kong (insurance activities), Thailand P&C, China P&C, South Korea, and Asia Holdings which are fully consolidated <sup>p. 47</sup>.
** China L&S, Thailand L&S, the Philippines L&S and P&C, Indonesia L&S and India (Life activities disposed on March 11, 2024 and holding) businesses which are consolidated under the equity method and contribute only to NBV, PVEP, the underlying earnings and net income <sup>p. 47</sup>.
** '''Africa''': Morocco (insurance activities and holding) and Nigeria (insurance activities and holding), Egypt (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** '''EME-LATAM''': Mexico (insurance activities), Colombia (insurance activities), Brazil (insurance activities and holding) and Türkiye (insurance activities and holding) which are fully consolidated <sup>p. 47</sup>.
** Russia (Reso) (insurance activities) iswhich consolidated under the equity method and contributes only to the net income <sup>p. 47</sup>.
** AXA Mediterranean Holdings <sup>p. 47</sup>.
* '''Transversal & Other''': includes AXA Assistance, AXA Liabilities Managers, AXA and other Central Holdings <sup>p. 47</sup>.
* '''AXA Investment Managers (until July 1, 2025)''': includes AXA Investment Managers, Select (previously referred to as Architas) and Capza which are fully consolidated and Asian joint ventures which are consolidated under the equity method <sup>p. 47</sup>.
* Unless otherwise specified, all comparative figures for going back to 2023 are under the IFRS17/9 accounting standards, that became effective on January 1, 2023 <sup>p. 47</sup>.
* Figures for financial periods prior to 2023 have not been restated under IFRS17/9 and are presented under IFRS4, the applicable accounting standard that preceded the implementation of IFRS17/9 <sup>p. 47</sup>.
 
=== Glossary ===
Line 1,218 ⟶ 955:
* '''Financial result''': consists of investment income on assets backing BBA and PAA contracts as well as assets backing shareholder's equity, net of the insurance finance expenses (IFE) defined as the unwind of the present value of future cash flow <sup>p. 48</sup>.
* '''Gross Written Premiums and Other Revenues (GWP & Other Revenues)''': represent the insurance premiums collected during the period (including risk premiums, premiums from pure investment contracts with no discretionary participating features, fees and revenues, net of commissions paid on assumed reinsurance business) <sup>p. 48</sup>.
** '''Other Revenues''': represent premiums and fees collected on activities other than insurance (i.e. banking, services, and asset management activities) <sup>p. 48</sup>.
* '''New Business Value (NBV)''': the value of newly issued contracts during the current year <sup>p. 48</sup>. It consists of the sum of: <sup>p. 48</sup>
** It consists of the sum of (i) the new business contractual service margin, (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals, (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of (iv) the cost of reinsurance, (v) taxes and (vi) minority interests <sup>p. 48</sup>.
** (i) the new business contractual service margin <sup>p. 48</sup>.
** (ii) the present value of the future profits of short-term newly issued contracts during the period, carried by Life entities, considering expected renewals <sup>p. 48</sup>.
** (iii) the present value of the future profits of pure investment contracts accounted for under IFRS 9, net of <sup>p. 48</sup>.
** (iv) the cost of reinsurance <sup>p. 48</sup>.
** (v) taxes <sup>p. 48</sup>.
** (vi) minority interests <sup>p. 48</sup>.
* '''New Business Contractual Service Margin (NB CSM)''': a component of the carrying amount of the asset or liability for newly issued insurance contracts during the period, representing the unearned profit to be recognized as insurance contract services are provided <sup>p. 48</sup>.
* '''New Business Value margin (NBV margin)''': ratio of (i) NBV, representing the value of newly issued contracts during the current year, to (ii) PVEP <sup>p. 48</sup>.
* '''Operating variance''': the variation of the year-end CSM versus the expected at opening due to (i) the differences between realized and expected operational assumptions, (ii) changes in assumptions such as mortality, longevity, lapses and expenses, and (iii) impact of model changes <sup>p. 48</sup>. Operating variance is net of reinsurance <sup>p. 48</sup>.
** Operating variance is net of reinsurance <sup>p. 48</sup>.
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term <sup>p. 48</sup>. PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>.
* '''Present value of expected premiums (PVEP)''': the new business volume, equal to the present value at the time of issue of the total premiums expected to be received over the policy term <sup>p. 48</sup>.
** PVEP is discounted at the reference interest rate and PVEP is Group share <sup>p. 48</sup>.
* '''Technical experience''': consists the impacts on the underlying earnings if (i) the difference between the expected and incurred cash-flows of the defined period, (ii) the risk adjustment release, (iii) the changes in onerous contracts, and (iv) the other long-term elements which are mainly composed of non-attributable expenses <sup>p. 48</sup>.
* '''Underlying return on in-force''': represents the release of Time Value of Options & Guarantees (TVOG) plus the unwind of CSM at the reference rate plus the underlying financial over-performance <sup>p. 48</sup>.
Line 1,241 ⟶ 975:
== Abbreviations ==
 
* '''AA''': Average rating
* '''AAA''': Average rating
* '''ABS''': Asset-Backed Securities
* '''AEP''': Aggregate Exceedance Probability
* '''AI''': Artificial Intelligence
* '''AMF''': Autorité des marchésMarchés financiersFinanciers
* '''APAC''': Asia-Pacific
* '''AY''': Accident Year
Line 1,254 ⟶ 986:
* '''CSA''': Corporate Sustainability Assessment
* '''CSM''': Contractual Service Margin
* '''CY''': CalendarCurrent Year
* '''DPS''': Dividend Per Share
* '''EME''': Europe,Emerging Middle EastMarkets
* '''EOF''': Eligible Own Funds
* '''EPS''': Earnings Per Share
Line 1,264 ⟶ 996:
* '''FX''': Foreign Exchange
* '''GAAP''': Generally Accepted Accounting Principles
* '''GEP''': Gross Earned PremiumsPremium
* '''GF EUR''': Grandfathered Euro
* '''GF GBP''': Grandfathered Great British Pound
* '''GWP''': Gross Written Premiums
* '''HKD''': Hong Kong Dollar
Line 1,273 ⟶ 1,003:
* '''IFRS''': International Financial Reporting Standards
* '''IG''': Investment Grade
* '''IIJPY''': SolvencyJapanese IIYen
* '''LATAM''': Latin America
* '''LTV''': Loan-to-Value
* '''MSCI''': Morgan Stanley Capital International
Line 1,281 ⟶ 1,012:
* '''NBV''': New Business Value
* '''NHG''': Nationale Hypotheek Garantie
* '''NPS''': Net Promoter Score
* '''OCI''': Other Comprehensive Income
* '''PAA''': Premium Allocation Approach
Line 1,287 ⟶ 1,017:
* '''PVEP''': Present Value of Expected Profits
* '''PYD''': Prior Years' Reserve Development
* '''RCG''': ReinsuranceReconciled CommissionCash and General ExpensesGenerated
* '''ROE''': Return On Equity
* '''SCR''': Solvency Capital Requirement